AustraliaAustralia's personal care and beauty sector is one of the Asia-Pacific region's most dynamic markets, governed by a rigorous multi-agency regulatory framework. Taevas Global helps manufacturers and brand owners navigate TGA, AICIS, and ACCC requirements s
Our six interconnected pillars give personal care and beauty manufacturers a complete, end-to-end view of what it takes to register, launch, and sustain compliant products in the Australian market.
Australia applies a tiered classification system where cosmetics, therapeutic goods, and chemical ingredients each fall under different regulatory pathways. We determine whether your product is a cosmetic under the ICNA Act, a listed or registered therapeutic good under the TGA, or triggers an AICIS industrial chemical notification. Correct classification at the outset prevents costly rework and delays.
Our four-phase engagement moves from rapid scoping through deep regulatory research, documentation preparation, and final delivery with expert briefing, giving your team everything needed to make confident market entry decisions.
We begin with a structured intake session to understand your product portfolio, formulations, intended claims, and commercial timeline. Using this information, we conduct an initial classification assessment to determine the applicable Australian regulatory pathway for each product. This step prevents misclassification errors that can cause significant delays later in the process.
Deliverables at this stage include a written classification opinion for each product, a regulatory pathway map identifying TGA, AICIS, and ACCC touchpoints, and a project plan with milestones and responsible parties. We also flag any early-stage red flags such as restricted actives or therapeutic claim risks that could affect your formulation or marketing strategy.
Australia is unique in applying both cosmetic and therapeutic goods frameworks to personal care products, with the TGA and AICIS operating in parallel. Products with active ingredient concentrations above prescribed thresholds shift from cosmetic to therapeutic good classification, triggering ARTG listing requirements. Navigating this boundary correctly is the single most critical compliance challenge for international brands entering Australia.
Australian consumers rank among the world's most ingredient-conscious, with demand for certified natural, cruelty-free, and microplastic-free formulations growing rapidly. Retailers including Mecca, Sephora Australia, and pharmacy chains are increasingly applying their own ingredient restriction lists beyond regulatory minimums. Brands entering Australia must align formulations with both regulatory and retailer standards simultaneously.
Online channels now account for approximately 20 percent of Australian beauty sales and are growing faster than bricks-and-mortar, driven by platforms including Adore Beauty, MECCA, and direct brand websites. Cross-border e-commerce from international brands also faces Australian customs and TGA import controls, making pre-market registration essential for sustained digital sales. Brands with compliant ARTG listings gain a significant trust advantage with Australian online shoppers.
New actives such as bakuchiol, CBD-derived compounds, and certain peptides are subject to heightened AICIS and TGA scrutiny in Australia, with some requiring pre-introduction assessments before any commercial use. The pace of ingredient innovation in global beauty formulation frequently outstrips existing Australian regulatory guidance, creating uncertainty for product developers. Early regulatory horizon scanning is essential for brands planning to launch next-generation formulations.
Every Taevas Global Product Registration engagement for Australia delivers a structured set of outputs designed to take your personal care and beauty products from formulation to compliant market launch.
A written classification and pathway assessment for each product in your portfolio, identifying all applicable Australian regulatory requirements under TGA, AICIS, and ACCC frameworks.
A comprehensive ingredient-level review against the TGA Cosmetics Standard 2007, the Poisons Standard, and AICIS chemical listings, with a prioritised remediation action list.
A structured gap analysis comparing your existing documentation and formulations against Australian regulatory requirements, with clear remediation steps and timelines.
A detailed review of all label artwork and marketing claims against Australian mandatory labelling standards and therapeutic claims guidance, with annotated change requirements.
Fully prepared and formatted application submissions for TGA ARTG listing or registration and AICIS introduction notifications, ready for lodgement with Australian regulators.
Preparation of all required Responsible Person declarations, importer records, and supply chain documentation to meet Australian sponsor and importer obligations.
A documented post-market surveillance plan covering adverse event reporting, product recall procedures, and ongoing compliance monitoring obligations under Australian law.
A structured handover session with your regulatory, marketing, and supply chain teams, including a 12-month compliance calendar and ongoing obligation summary.
You have a proven product range in your home market and are ready to expand into Australia, but the dual TGA and AICIS regulatory landscape is unfamiliar territory. Your formulations may include actives that are unrestricted elsewhere but require special handling in Australia. You need a partner who can classify your products correctly, identify reformulation risks early, and manage the entire registration process on your behalf.
Whether you are launching your first product in Australia or scaling an existing portfolio, Taevas Global provides the regulatory expertise and market intelligence to get your personal care and beauty brand to market compliantly and efficiently. Speak with our Australia regulatory team today.